Celine Halioua is the Founder & CEO of Loyal - the first company to ever receive FDA approval to develop a drug to extend lifespan in dogs, and they have raised $125mm from Bain Capital Ventures, Khosla Ventures, First Round and others to do so. By building a blockbuster longevity drug for dugs, Loyal aims to lay the foundation for safe and effective longevity drugs in humans. In this interview, Celine describes her thesis that longevity drugs should be boring, what it means to create a new market, how charlatans put the whole longevity field at risk, and much more. We hope you enjoy this episode.